Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 1
1997 1
1998 7
1999 4
2000 2
2002 3
2003 2
2004 2
2005 5
2007 4
2008 3
2009 3
2010 3
2011 2
2013 3
2014 5
2015 4
2016 3
2017 6
2018 4
2019 3
2020 2
2021 7
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study.
Wada T, Yamakawa K, Kabata D, Abe T, Fujishima S, Kushimoto S, Mayumi T, Ogura H, Saitoh D, Shiraishi A, Otomo Y, Gando S; JAAM FORECAST Group. Wada T, et al. J Intensive Care. 2023 Mar 5;11(1):8. doi: 10.1186/s40560-023-00656-5. J Intensive Care. 2023. PMID: 36872342 Free PMC article.
Transcriptional control of T-cell development.
Naito T, Tanaka H, Naoe Y, Taniuchi I. Naito T, et al. Among authors: naoe y. Int Immunol. 2011 Nov;23(11):661-8. doi: 10.1093/intimm/dxr078. Epub 2011 Sep 23. Int Immunol. 2011. PMID: 21948191 Review.
Comparing post-hospital care pathways following hip fracture.
Koyama Y, Minamibata S, Naoe Y, Hori S, Kato Y, Momosaki R. Koyama Y, et al. Among authors: naoe y. Disabil Rehabil. 2022 Aug;44(16):4546. doi: 10.1080/09638288.2021.1923070. Epub 2021 May 23. Disabil Rehabil. 2022. PMID: 34027752 No abstract available.
STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA, Matsumura S, Ichinose T, Bustos-Villalobos I, Morimoto D, Eissa IR, Abdelmoneim M, Aboalela MAM, Mukoyama N, Tanaka M, Naoe Y, Kasuya H. Sibal PA, et al. Among authors: naoe y. Mol Oncol. 2024 May;18(5):1259-1277. doi: 10.1002/1878-0261.13603. Epub 2024 Feb 23. Mol Oncol. 2024. PMID: 38400597 Free PMC article.
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: naoe y. Cancers (Basel). 2018 Sep 26;10(10):356. doi: 10.3390/cancers10100356. Cancers (Basel). 2018. PMID: 30261620 Free PMC article. Review.
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.
Eissa IR, Naoe Y, Bustos-Villalobos I, Ichinose T, Tanaka M, Zhiwen W, Mukoyama N, Morimoto T, Miyajima N, Hitoki H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: naoe y. Front Oncol. 2017 Jul 14;7:149. doi: 10.3389/fonc.2017.00149. eCollection 2017. Front Oncol. 2017. PMID: 28770166 Free PMC article. Review.
88 results